Login to Your Account

Washington Roundup

Amylin Loses Preliminary Round of Lilly Fight over Byetta

By Mari Serebrov
Washington Editor

Thursday, November 3, 2011

Amylin Pharmaceutical Inc. lost its preliminary bid to block Eli Lilly and Co. from jointly promoting diabetes drugs Byetta and Tradjenta, but its underlying challenge to Lilly's marketing strategy has yet to get its day in court.

A U.S.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription